메뉴 건너뛰기




Volumn 17, Issue 5, 2010, Pages 576-581

Guideline-recommended secondary prevention drug therapy after acute myocardial infarction: Predictors and outcomes of nonadherence

Author keywords

acute myocardial infarction; clinical practice; comorbidity; guideline adherence; mortality; secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SARTAN DERIVATIVE;

EID: 77957803601     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e328338e5da     Document Type: Article
Times cited : (44)

References (31)
  • 1
    • 65849268320 scopus 로고    scopus 로고
    • Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
    • Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R etal; Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849–1860.
    • (2009) Lancet , vol.373 , pp. 1849-1860
    • Baigent, C.1    Blackwell, L.2    Collins, R.3    Emberson, J.4    Godwin, J.5    Peto, R.6
  • 2
    • 0036023515 scopus 로고    scopus 로고
    • Treatment with atorvastatin to the National Cholesterol Educational Program goal versus usual care in secondary coronary heart disease prevention: the Greek Atorvastatin and Coronary-Heart-Disease Evaluation (GREACE) Study
    • Athyros VG, Papageorgiou AA, Mercouris BR, Athyrou VV, Symeonidis AN, Basayannis EO, et al Treatment with atorvastatin to the National Cholesterol Educational Program goal versus usual care in secondary coronary heart disease prevention: the Greek Atorvastatin and Coronary-Heart-Disease Evaluation (GREACE) Study. Curr Med Res Opin 2002; 18: 220–228.
    • (2002) Curr Med Res Opin , vol.18 , pp. 220-228
    • Athyros, V.G.1    Papageorgiou, A.A.2    Mercouris, B.R.3    Athyrou, V.V.4    Symeonidis, A.N.5    Basayannis, E.O.6
  • 3
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
    • Long-Term Intervention With Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N EnglJ Med 1998; 339: 1349–1357.
    • (1998) N EnglJ Med , vol.339 , pp. 1349-1357
  • 4
    • 4143126680 scopus 로고    scopus 로고
    • Task Force on ACE-inhibitors of the European Society of Cardiology. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology
    • López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H etal; Task Force on ACE-inhibitors of the European Society of Cardiology. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J 2004; 25: 1454–1470.
    • (2004) Eur Heart J , vol.25 , pp. 1454-1470
    • López-Sendón, J.1    Swedberg, K.2    McMurray, J.3    Tamargo, J.4    Maggioni, A.P.5    Dargie, H.6
  • 5
    • 3442901436 scopus 로고    scopus 로고
    • Task ForceOn Beta-Blockers of the European Society of Cardiology. Expert consensus document on beta-adrenergic receptor blockers
    • López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H etal; Task ForceOn Beta-Blockers of the European Society of Cardiology. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 2004; 25: 1341–1362.
    • (2004) Eur Heart J , vol.25 , pp. 1341-1362
    • López-Sendón, J.1    Swedberg, K.2    McMurray, J.3    Tamargo, J.4    Maggioni, A.P.5    Dargie, H.6
  • 6
    • 0037454048 scopus 로고    scopus 로고
    • Short-and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention
    • Mehta SR, Yusuf S. Short-and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. J Am Coll Cardiol 2003; 41 (4 Suppl S):79S–88S.
    • (2003) J Am Coll Cardiol , vol.41 , Issue.4 , pp. 79S-88S
    • Mehta, S.R.1    Yusuf, S.2
  • 7
    • 0342981862 scopus 로고    scopus 로고
    • The effects of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial Investigators. For the TNT Study Group
    • Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al The effects of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial Investigators. For the TNT Study Group. N Engl J Med 1996; 335: 1001–1009.
    • (1996) N Engl J Med , vol.335 , pp. 1001-1009
    • Sacks, F.M.1    Pfeffer, M.A.2    Moye, L.A.3    Rouleau, J.L.4    Rutherford, J.D.5    Cole, T.G.6
  • 8
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study
    • Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study. Lancet 1994; 344: 1383–1389.
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 9
    • 57349189353 scopus 로고    scopus 로고
    • Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology
    • Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29: 2909–2945.
    • (2008) Eur Heart J , vol.29 , pp. 2909-2945
    • Van de Werf, F.1    Bax, J.2    Betriu, A.3    Blomstrom-Lundqvist, C.4    Crea, F.5    Falk, V.6
  • 10
    • 39149123172 scopus 로고    scopus 로고
    • Medication adherence after myocardial infarction: a long way left to go
    • Choudhry NK, Winkelmayer WC. Medication adherence after myocardial infarction: a long way left to go. J Gen Intern Med 2008; 23: 216–218.
    • (2008) J Gen Intern Med , vol.23 , pp. 216-218
    • Choudhry, N.K.1    Winkelmayer, W.C.2
  • 11
    • 57149084663 scopus 로고    scopus 로고
    • Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998–2006
    • Fonarow GC, French WJ, Frederick PD. Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998–2006. Am Heart J 2009; 157: 185–194.
    • (2009) Am Heart J , vol.157 , pp. 185-194
    • Fonarow, G.C.1    French, W.J.2    Frederick, P.D.3
  • 12
    • 0029739435 scopus 로고    scopus 로고
    • Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985–1993
    • Koenig W, Löwel H, Lewis M, Hörmann A. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985–1993. Eur Heart J 1996; 17: 1199–1206.
    • (1996) Eur Heart J , vol.17 , pp. 1199-1206
    • Koenig, W.1    Löwel, H.2    Lewis, M.3    Hörmann, A.4
  • 13
    • 61849163580 scopus 로고    scopus 로고
    • EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
    • Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009; 16: 121–137.
    • (2009) Eur J Cardiovasc Prev Rehabil , vol.16 , pp. 121-137
    • Kotseva, K.1    Wood, D.2    De Backer, G.3    De Bacquer, D.4    Pyörälä, K.5    Keil, U.6
  • 14
    • 33846123697 scopus 로고    scopus 로고
    • Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction
    • Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007; 297: 177–186.
    • (2007) JAMA , vol.297 , pp. 177-186
    • Rasmussen, J.N.1    Chong, A.2    Alter, D.A.3
  • 15
  • 16
    • 34547938307 scopus 로고    scopus 로고
    • American College of Cardiology Foundation Bethesda, MD. The association between guideline-based treatment instructions at the point of discharge and lower 1-year mortality in Medicare patients after acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) initiative in Michigan
    • Rogers AM, Ramanath VS, Grzybowski M, Riba AL, Jani SM, Mehta R etal; American College of Cardiology Foundation Bethesda, MD. The association between guideline-based treatment instructions at the point of discharge and lower 1-year mortality in Medicare patients after acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) initiative in Michigan. Am Heart J 2007; 154: 461–469.
    • (2007) Am Heart J , vol.154 , pp. 461-469
    • Rogers, A.M.1    Ramanath, V.S.2    Grzybowski, M.3    Riba, A.L.4    Jani, S.M.5    Mehta, R.6
  • 17
    • 35348980852 scopus 로고    scopus 로고
    • Reinforcing a continuum of care: in-hospital initiation of long-term secondary prevention following acute coronary syndromes
    • Rockson SG, deGoma EM, Fonarow GC. Reinforcing a continuum of care: in-hospital initiation of long-term secondary prevention following acute coronary syndromes. Cardiovasc Drugs Ther 2007; 21: 375–388.
    • (2007) Cardiovasc Drugs Ther , vol.21 , pp. 375-388
    • Rockson, S.G.1    deGoma, E.M.2    Fonarow, G.C.3
  • 19
    • 66749150617 scopus 로고    scopus 로고
    • Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database
    • Tuppin P, Neumann A, Danchin N, Weill A, Ricordeau P, de Peretti C, et al Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database. Arch Cardiovasc Dis 2009; 102: 279–292.
    • (2009) Arch Cardiovasc Dis , vol.102 , pp. 279-292
    • Tuppin, P.1    Neumann, A.2    Danchin, N.3    Weill, A.4    Ricordeau, P.5    de Peretti, C.6
  • 20
    • 34547772153 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and treatment of non-ST -segment elevation acute coronary syndromes
    • Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, et al Guidelines for the diagnosis and treatment of non-ST -segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1598–1660.
    • (2007) Eur Heart J , vol.28 , pp. 1598-1660
    • Bassand, J.P.1    Hamm, C.W.2    Ardissino, D.3    Boersma, E.4    Budaj, A.5    Fernández-Avilés, F.6
  • 21
    • 0035899289 scopus 로고    scopus 로고
    • Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
    • Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494–502.
    • (2001) N Engl J Med , vol.345 , pp. 494-502
    • Yusuf, S.1    Zhao, F.2    Mehta, S.R.3    Chrolavicius, S.4    Tognoni, G.5    Fox, K.K.6
  • 23
    • 0141725727 scopus 로고    scopus 로고
    • Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis
    • Salpeter SR, Ormiston TM, Salpeter EE, Poole PJ, Cates CJ. Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis. Respir Med 2003; 97: 1094–1101.
    • (2003) Respir Med , vol.97 , pp. 1094-1101
    • Salpeter, S.R.1    Ormiston, T.M.2    Salpeter, E.E.3    Poole, P.J.4    Cates, C.J.5
  • 24
    • 0025992650 scopus 로고
    • Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials
    • Radack K, Deck C. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. Arch Intern Med 1991; 151: 1769–1776.
    • (1991) Arch Intern Med , vol.151 , pp. 1769-1776
    • Radack, K.1    Deck, C.2
  • 25
    • 1442306996 scopus 로고    scopus 로고
    • Management of peripheral arterial disease of the lower extremities in elderly patients
    • Aronow WS. Management of peripheral arterial disease of the lower extremities in elderly patients. J Gerontol Med Sci 2004; 59: 172–177.
    • (2004) J Gerontol Med Sci , vol.59 , pp. 172-177
    • Aronow, W.S.1
  • 26
    • 30444452987 scopus 로고    scopus 로고
    • Efficacy and safety of benazepril for advanced chronic renal insufficiency
    • Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, et al Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 2006; 354: 131–140.
    • (2006) N Engl J Med , vol.354 , pp. 131-140
    • Hou, F.F.1    Zhang, X.2    Zhang, G.H.3    Xie, D.4    Chen, P.Y.5    Zhang, W.R.6
  • 27
    • 42749099562 scopus 로고    scopus 로고
    • Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease
    • Strippoli GFM, Bonifati C, Craig M, Navaneethan SD, Craig JC. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database of Systematic Reviews 2006; 4: CD006257.
    • (2006) Cochrane Database of Systematic Reviews , vol.4 , pp. CD006257
    • Strippoli, G.F.M.1    Bonifati, C.2    Craig, M.3    Navaneethan, S.D.4    Craig, J.C.5
  • 28
    • 0030118977 scopus 로고    scopus 로고
    • Bethesda Conference. Matching the intensity of risk factor management with the hazard for coronary disease events: September 14–15, 1995
    • Bethesda Conference. Matching the intensity of risk factor management with the hazard for coronary disease events: September 14–15, 1995. J Am Coll Cardiol 1996; 27: 957–1047.
    • (1996) J Am Coll Cardiol , vol.27 , pp. 957-1047
  • 30
    • 26844540510 scopus 로고    scopus 로고
    • Evolution in cardiovascular care for elderly patients with Non-ST-segment elevation acute coronary syndromes
    • Alexander KP, Roe MT, Chen AY, Lytle BL, Pollack CV Jr., Foody JM etal; for the CRUSADE Investigators. Evolution in cardiovascular care for elderly patients with Non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2005; 46: 1479–1487.
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1479-1487
    • Alexander, K.P.1    Roe, M.T.2    Chen, A.Y.3    Lytle, B.L.4    Pollack, C.V.5    Foody, J.M.6
  • 31
    • 33645025131 scopus 로고    scopus 로고
    • Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey
    • Rosengren A, Wallentin L, Simoons M, Gitt AK, Behar S, Battler A, et al Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Eur Heart J 2006; 27: 789–795.
    • (2006) Eur Heart J , vol.27 , pp. 789-795
    • Rosengren, A.1    Wallentin, L.2    Simoons, M.3    Gitt, A.K.4    Behar, S.5    Battler, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.